These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 23307479
1. Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications. Wilson TJ, McKean EL, Barkan AL, Chandler WF, Sullivan SE. Pituitary; 2013 Dec; 16(4):459-64. PubMed ID: 23307479 [Abstract] [Full Text] [Related]
2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G. Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [Abstract] [Full Text] [Related]
4. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [Abstract] [Full Text] [Related]
11. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA. J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543 [Abstract] [Full Text] [Related]
12. Predictors of surgical outcome and early criteria of remission in acromegaly. Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM, Camacho AHS, Chimelli L, Niemeyer P, Gadelha MR, Kasuki L. Endocrine; 2018 Jun; 60(3):415-422. PubMed ID: 29626274 [Abstract] [Full Text] [Related]
14. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M. J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496 [Abstract] [Full Text] [Related]
15. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Biermasz NR, van Dulken H, Roelfsema F. J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114 [Abstract] [Full Text] [Related]
16. Decrease of Serum IGF-I following Transsphenoidal Pituitary Surgery for Acromegaly. Yu M, Bruns DE, Jane JA, Nass RM, Oldfield EH, Vance ML, Thorner MO. Clin Chem; 2017 Feb; 63(2):486-494. PubMed ID: 27974387 [Abstract] [Full Text] [Related]
17. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598 [Abstract] [Full Text] [Related]
18. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH. J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548 [Abstract] [Full Text] [Related]
19. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Nomikos P, Buchfelder M, Fahlbusch R. Eur J Endocrinol; 2005 Mar; 152(3):379-87. PubMed ID: 15757854 [Abstract] [Full Text] [Related]
20. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery. Taweesomboonyat C, Oearsakul T. World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]